biotech

Showing 15 posts of 861 posts found.

satu1028-pano_1024_px

EMA set to also revise guidelines of Alzheimer’s trials

February 28, 2018
Medical Communications Alzheimer's, EMA, FDA, biotech, drugs, pharma, pharmaceutical

The EMA, following on from the FDA’s lead earlier this month, has announced that it will revise its guidelines on …

anatomy-3003099_960_720

Stem cell therapy offers hope for spinal cord injuries

February 28, 2018
Research and Development biotech, drugs, pharma, pharmaceutical, stem cell, stem cell treatment

Scientists have brought the prospect of spinal cord injuries being able to be treated with stem cells one step closer, …

AstraZeneca creates biotech spin-off, $250m in bank

February 28, 2018
Research and Development, Sales and Marketing AstraZeneca, Viela, biotech, drugs, pharma, pharmaceutical

Biotechs created from big pharma companies tend to have an easier start to life than most, and this is definitely …

dna

Generation Bio backed with $100m financing round

February 28, 2018
Research and Development, Sales and Marketing Generation Bio, biotech, drugs, pharma, pharmaceutical

At the start of year, Generation Bio was revealed to the public, announcing that it had been developing gene therapies …

Allergan’s patent gamble fails

February 27, 2018
Manufacturing and Production, Medical Communications Allergan, Mylan, biotech, drugs, patent, pharma, pharmaceutical

Allergan’s patent deal with the Saint Regis Mohawk Tribe, in an attempt to protect itself from an inter partes review …

vaccination-2722937_960_720

UK govt report looks to reduce vaccination spending

February 27, 2018
Manufacturing and Production, Medical Communications Vaccine, biotech, drugs, meningitis, pharma, pharmaceutical

One of the largest petitions ever to have gone before UK parliament, after it attracted 823,349 signatures, brought about the …

nhs_trees

UK to crack down on 237m annual medication errors

February 23, 2018
Medical Communications Jeremy Hunt, NHS, biotech, drugs, pharma, pharmaceutical

A new study commissioned by the Department of Health and Social Care has revealed that 237 million medication errors are …

tumour_growing_jan-chlebik-for-the-icr-2013

Lab-grown tumours able to predict drug efficacy

February 23, 2018
Medical Communications, Research and Development biotech, drugs, pharma, pharmaceutical

One of the key challenges facing the treatment of cancer is knowing whether a particular drug will work with an …

gilead-sciences

Gilead seals $3bn deal, hoping for off-the-shelf CAR-T

February 23, 2018
Medical Communications, Sales and Marketing CAR-T, Gilead, Kite, Sangamo Therapeutics, biotech, drugs, pharma, pharmaceutical

The expense and laborious process involved in bringing CAR-T therapies to patients was used a key reason for the high …

bens1

AllTrials puts FDA under pressure with Trials Tracker

February 22, 2018
Medical Communications alltrials, biotech, drugs, pharma, pharmaceutical

A year to the day that the FDA unveiled its Final Rule, which sees organisation given 13 months from clinical …

flumist

CDC U-turns previous decision on AZ’s flu vaccine

February 22, 2018
Sales and Marketing AstraZeneca, Vaccine, biotech, drugs, flu, influenza, pharma, pharmaceutical

The US Centers for Disease Control and Prevention (CDC) has now recommended AstraZeneca’s FluMist as an option for doctors for …

greek_parliament

Greek parliament moves to investigate 10 politicians

February 22, 2018
Medical Communications, Sales and Marketing Greece, Greek Parliament, Novartis, biotech, drugs, pharma, pharmaceutical

After a 20-hour debate, Greek parliament has voted in favour of investigating 10 politicians named as part of an investigation …

astrazeneca_logo_building

AZ licenses kidney drug from Ionis for $330m

February 21, 2018
Research and Development, Sales and Marketing AstraZeneca, Ionis, Isis, biotech, drugs, kidney, pharma, pharmaceutical

AstraZeneca continues to build on its relationship with San Diego-based Ionis Pharmaceuticals, this time by agreeing a licensing deal for …

abbviehqe_004_low

AbbVie turns to tau for Alzheimer’s in $1.1bn deal

February 21, 2018
Research and Development, Sales and Marketing AbbVie, Alzheimer's, Voyager, biotech, drugs, pharma, pharmaceutical

Sailing against the prevailing winds in the Alzheimer’s disease space, AbbVie has launched a deal worth a potential $1.1 billion …

heart_rope

Google develops AI to predict cardiovascular risk

February 21, 2018
Research and Development AI, Verily Life Sciences, biotech, cardiovascular, drugs, google, pharma, pharmaceutical

Google and Verily Life Sciences, a subsidiary within Alphabet, focused on developing health-tech, have revealed the fruits of a combined …

The Gateway to Local Adoption Series

Latest content